Citation Impact
Citing Papers
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
2015 Nobel
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
2009 Standout
Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators
2006 Standout
Molecular mechanisms of L-DOPA-induced dyskinesia
2008
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
2007 Standout
p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism
2002
Parkinson's disease
2021 Standout
Single-cell-resolution transcriptome map of human, chimpanzee, bonobo, and macaque brains
2020 StandoutNobel
Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
2005
DeepLabCut: markerless pose estimation of user-defined body parts with deep learning
2018 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
Glutamate uptake
2001 Standout
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Training-induced structural changes in the adult human brain
2008
Dopamine depletion increases the power and coherence of β‐oscillations in the cerebral cortex and subthalamic nucleus of the awake rat
2005
Motor Impairments, Striatal Degeneration, and Altered Dopamine-Glutamate Interplay in Mice Lacking PSD-95
2014
Exosomes in the Pathology of Neurodegenerative Diseases
2016
l-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain
2004
Spreading of pathology in neurodegenerative diseases: a focus on human studies
2015
Structure-Guided Directed Evolution of Highly Selective P450-Based Magnetic Resonance Imaging Sensors for Dopamine and Serotonin
2012 StandoutNobel
Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain
2007 Standout
RGS9–2 Negatively Modulates l-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease
2007
Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease
2004
Tau in physiology and pathology
2015 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease
2011
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Parkinson's disease
2015 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Molecular chaperones in protein folding and proteostasis
2011 StandoutNature
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
2005 StandoutNobel
2008
Enriched environments influence depression-related behavior in adult mice and the survival of newborn cells in their hippocampi
2007
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Musical Training Shapes Structural Brain Development
2009 Standout
Metabolism and functions of glutathione in brain
2000 Standout
Major Depressive Disorder
2008 Standout
Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally
2006
Non-motor features of Parkinson disease
2017 Standout
Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in L-DOPA-Induced Dyskinesia
2007
Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in Mice
2009
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
2014
MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease
2004
Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function
2009
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Monoamine transporter pharmacology and mutant mice
2002
Neurodegenerative diseases and oxidative stress
2004 Standout
O-GlcNAc modification of small heat shock proteins enhances their anti-amyloid chaperone activity
2021 StandoutNobel
Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity
2016
Evolution of primate gene expression
2006 StandoutNobel
The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
2014
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
Parkinson's Disease
2003 Standout
Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in Rodents
2018
Neurochemistry of Parkinson's disease
2007
Physiology and Pathophysiology of Carnosine
2013 Standout
Neurodegenerative Diseases: Expanding the Prion Concept
2015
Antibody-Mediated Encephalitis
2018 Standout
Progressive Dopamine Neuron Loss in Parkinson's Disease: The Multiple Hit Hypothesis
2006
Closed-loop neuromodulation of spinal sensorimotor circuits controls refined locomotion after complete spinal cord injury
2014
Diagnosis and Treatment of Parkinson Disease
2020 Standout
The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease.
2003
The 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mouse Model
2003
Systemic exosomal siRNA delivery reduced alpha‐synuclein aggregates in brains of transgenic mice
2014
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
2018
α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson’s disease
2019
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter
1999
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Long oligonucleotide microarrays for African green monkey gene expression profile analysis
2007 StandoutNobel
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer’s and Parkinson’s diseases1,2 11Guest Editors: Mark A. Smith and George Perry 22This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers may be found on the homepage of the journal.
2002
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
2004 StandoutScience
Neuroleptic intolerance in patients with anti-NMDAR encephalitis
2016
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Monoamine Transporters: From Genes to Behavior
2003
Antioxidative and Anti-Inflammatory Protection from Carnosine in the Striatum of MPTP-Treated Mice
2010
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
2003 StandoutScience
Extending Healthy Life Span—From Yeast to Humans
2010 StandoutScience
Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders
2015
Physiology of Microglia
2011 Standout
Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP‐induced neurotoxicity: role of TNF‐α 1
2006
Microarray analysis of nonhuman primates: validation of experimental models in neurological disorders
2003
Molecular Genetics of Attention-Deficit/Hyperactivity Disorder
2005 Standout
Works of Sandra Doveró being referenced
Lentiviral Overexpression of GRK6 Alleviates l -Dopa–Induced Dyskinesia in Experimental Parkinson’s Disease
2010
IGF-1 signaling reduces neuro-inflammatory response and sensitivity of neurons to MPTP
2008
Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine Transporter
1999
Kinetics of nigral degeneration in a chronic model of MPTP-treated mice
1997
Involvement of Sensorimotor, Limbic, and Associative Basal Ganglia Domains in L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia
2005
Coordinated reset has sustained aftereffects in Parkinsonian monkeys
2012
Levodopa‐induced dyskinesia in MPTP‐treated macaques is not dependent on the extent and pattern of nigrostrial lesioning
2005
Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei
2003
Enhanced Preproenkephalin-B–Derived Opioid Transmission in Striatum and Subthalamic Nucleus Converges Upon Globus Pallidus Internalis in L-3,4-dihydroxyphenylalanine–Induced Dyskinesia
2006
Distinct Changes in cAMP and Extracellular Signal-Regulated Protein Kinase Signalling in L-DOPA-Induced Dyskinesia
2010
PSD-95 expression controls l-DOPA dyskinesia through dopamine D1 receptor trafficking
2012
Effects of Different Schedules of MPTP Administration on Dopaminergic Neurodegeneration in Mice
1997
Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia
2004
Pattern of levodopa‐induced striatal changes is different in normal and MPTP‐lesioned mice
2003
Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys
2013
Enriched Environment Confers Resistance to 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine and Cocaine: Involvement of Dopamine Transporter and Trophic Factors
2003
Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
2001
Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with l -dopa–induced dyskinesia
2010